These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 31377895)
1. Vaginal CO Pearson A; Booker A; Tio M; Marx G Breast Cancer Res Treat; 2019 Nov; 178(1):135-140. PubMed ID: 31377895 [TBL] [Abstract][Full Text] [Related]
2. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy. Salvatore S; Nappi RE; Parma M; Chionna R; Lagona F; Zerbinati N; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U Climacteric; 2015 Apr; 18(2):219-25. PubMed ID: 25333211 [TBL] [Abstract][Full Text] [Related]
3. Understanding the Benefits of CO Jankovic S; Rovcanin M; Tomic A; Jurisic A; Milovanovic Z; Zamurovic M Medicina (Kaunas); 2024 Jun; 60(7):. PubMed ID: 39064488 [No Abstract] [Full Text] [Related]
4. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832 [TBL] [Abstract][Full Text] [Related]
5. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy. Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104 [TBL] [Abstract][Full Text] [Related]
6. Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial. Hersant B; Werkoff G; Sawan D; Sidahmed-Mezi M; Bosc R; La Padula S; Kalsoum S; Ouidir N; Meningaud JP; Belkacemi Y Ann Chir Plast Esthet; 2020 Jul; 65(4):e23-e31. PubMed ID: 32513482 [TBL] [Abstract][Full Text] [Related]
7. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Pieralli A; Fallani MG; Becorpi A; Bianchi C; Corioni S; Longinotti M; Tredici Z; Guaschino S Arch Gynecol Obstet; 2016 Oct; 294(4):841-6. PubMed ID: 27170261 [TBL] [Abstract][Full Text] [Related]
8. Microablative Fractional CO Salvatore S; Nappi RE; Casiraghi A; Ruffolo AF; Degliuomini R; Parma M; Leone Roberti Maggiore U; Athanasiou S; Candiani M Clin Breast Cancer; 2021 Oct; 21(5):e539-e546. PubMed ID: 33745867 [TBL] [Abstract][Full Text] [Related]
9. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device. Vicariotto F; Raichi M Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062 [TBL] [Abstract][Full Text] [Related]
10. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Perino A; Calligaro A; Forlani F; Tiberio C; Cucinella G; Svelato A; Saitta S; Calagna G Maturitas; 2015 Mar; 80(3):296-301. PubMed ID: 25596815 [TBL] [Abstract][Full Text] [Related]
12. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety. Vicariotto F; DE Seta F; Faoro V; Raichi M Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667 [TBL] [Abstract][Full Text] [Related]
13. Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study. Pagano T; De Rosa P; Vallone R; Schettini F; Arpino G; De Placido S; Nazzaro G; Locci M; De Placido G Menopause; 2016 Oct; 23(10):1108-13. PubMed ID: 27648595 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of non-ablative CO Lami A; Alvisi S; Baldassarre M; Zanella S; Amati V; Seracchioli R; Meriggiola MC Arch Gynecol Obstet; 2024 Apr; 309(4):1575-1583. PubMed ID: 38253692 [TBL] [Abstract][Full Text] [Related]
15. CO Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study. De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Hersant B; SidAhmed-Mezi M; Belkacemi Y; Darmon F; Bastuji-Garin S; Werkoff G; Bosc R; Niddam J; Hermeziu O; La Padula S; Meningaud JP Menopause; 2018 Oct; 25(10):1124-1130. PubMed ID: 29738415 [TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Cruz VL; Steiner ML; Pompei LM; Strufaldi R; Fonseca FLA; Santiago LHS; Wajsfeld T; Fernandes CE Menopause; 2018 Jan; 25(1):21-28. PubMed ID: 28763401 [TBL] [Abstract][Full Text] [Related]
20. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women. Panay N; Palacios S; Bruyniks N; Particco M; Nappi RE; Maturitas; 2019 Jun; 124():55-61. PubMed ID: 31097180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]